Back
NeuroBo Pharmaceuticals Quote, Financials, Valuation and Earnings
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
26
NRBO
NeuroBo Pharmaceuticals
Last Price:
2.41
Seasonality Move:
-8.74%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.NeuroBo Pharmaceuticals Price Quote
$2.41
-0.15 (-5.86%)
(Updated: November 14, 2024 at 5:55 PM ET)
NeuroBo Pharmaceuticals Key Stats
Sell
26
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Day range:
$2.37 - $2.68
52-week range:
$2.08 - $6.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.15%
Volume:
67.5K
Avg. volume:
37.2K
1-year change:
-27.11%
Market cap:
$21.7M
Revenue:
$0
EPS:
$-4.91
How Much Does NeuroBo Pharmaceuticals Make?
Data Unavailable
Is NeuroBo Pharmaceuticals Growing As A Company?
Data Unavailable
NeuroBo Pharmaceuticals Stock Price Performance
-
Did NeuroBo Pharmaceuticals Stock Go Up Last Month?
NeuroBo Pharmaceuticals share price went up by 0% last month -
Did NRBO's Share Price Rise Over The Last Year?
NRBO share price fell by -27.11% over the past 1 year
What Is NeuroBo Pharmaceuticals 52-Week High & Low?
-
What Is NeuroBo Pharmaceuticals’s 52-Week High Share Price?
NeuroBo Pharmaceuticals has traded as high as $6.75 over the past 52 weeks -
What Is NeuroBo Pharmaceuticals’s 52-Week Low Share Price?
NeuroBo Pharmaceuticals has traded as low as $2.08 over the past 52 weeks
NeuroBo Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy NeuroBo Pharmaceuticals?
-
How Much Debt Does NeuroBo Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does NeuroBo Pharmaceuticals Have?
Cash and short term investments quarterly total is $27.9M -
What Is NeuroBo Pharmaceuticals’s Book Value Per Share?
Book value per share is 2.30
Is NeuroBo Pharmaceuticals Cash Flow Positive?
-
What Is NRBO Cash Flow From Operations?
Cash flow from operations (TTM) is -$19.9M -
What Is NeuroBo Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $19.2M -
What Is NeuroBo Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$54K
NeuroBo Pharmaceuticals Return On Invested Capital
Data Unavailable
NeuroBo Pharmaceuticals Earnings Date & Stock Price
-
What Is NeuroBo Pharmaceuticals's Stock Price Today?
A single share of NRBO can be purchased today for 2.56 -
What Is NeuroBo Pharmaceuticals’s Stock Symbol?
NeuroBo Pharmaceuticals trades on the nasdaq under the ticker symbol: NRBO -
When Is NeuroBo Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for NeuroBo Pharmaceuticals is scheduled on May 9, 2025 -
When Is NRBO's next ex-dividend date?
NeuroBo Pharmaceuticals's next ex-dividend date is November 15, 2024 -
How To Buy NeuroBo Pharmaceuticals Stock?
You can buy NeuroBo Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
NeuroBo Pharmaceuticals Competitors
-
Who Are NeuroBo Pharmaceuticals's Competitors?
Below is a list of companies who compete with NeuroBo Pharmaceuticals or are related in some way:
NeuroBo Pharmaceuticals Dividend Yield
-
What Is NRBO Dividend Yield?
NeuroBo Pharmaceuticals’s dividend yield currently is 0% -
What Is NeuroBo Pharmaceuticals’s Payout Ratio?
NeuroBo Pharmaceuticals’s payout ratio is 0% -
When Did NeuroBo Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is NeuroBo Pharmaceuticals’s Dividend Per Share?
NeuroBo Pharmaceuticals pays a dividend of $0.00 per share
NeuroBo Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 26.67 |
| Upside from Last Price: | 941.67% |